Korea McNulty Posts 15% Increase in Q3 Sales and Turns to Operating Profit
Hwang Sujin Reporter
hwang075609@gmail.com | 2026-11-16 10:25:54
Korea McNulty (CEO Lee Eun-jung) has achieved both consolidated revenue growth and a turnaround to operating profit in the third quarter of this year. While its core coffee business maintained stable profits, improved profitability from its pharmaceutical and health functional food subsidiaries drove the overall performance growth.
Korea McNulty announced on the 16th that it recorded consolidated revenue of 28.6 billion KRW and an operating profit of 1.3 billion KRW for the third quarter. Revenue increased by 15.3% compared to 24.8 billion KRW in the same period last year, and operating profit turned a profit from a loss of 900 million KRW a year earlier. On a cumulative basis for the first to third quarters, the company recorded revenue of 79.0 billion KRW and an operating profit of 1.6 billion KRW, up 6.4% and turning a profit year-on-year, respectively. Cumulative net income also turned to a profit of approximately 100 million KRW.
The improvement in profitability was supported by the recovery of subsidiary performances. McNulty Pharma saw cumulative revenue grow by 10.6% year-on-year to 18.7 billion KRW, turning a profit with an operating profit of 500 million KRW compared to an operating loss of 400 million KRW in the same period last year. McNulty Bio, which handles the health functional food business, also saw cumulative revenue surge by 72.6% to 9.1 billion KRW and turned a profit with an operating profit of 200 million KRW. The core coffee business maintained a stable profit base, recording a cumulative operating profit of 900 million KRW, up 50.2% year-on-year.
McNulty Bio's revenue growth was led by the expansion of OEM/ODM production for external brand clients. While expanding production collaborations with companies such as Adapt and J.Bio, the company is broadening its business scope by launching its own brand product, "Sense Cut Black Cumin," based on "black cumin extract," an independently recognized raw material approved by the Ministry of Food and Drug Safety for its body fat reduction functionality.
McNulty Pharma is working to strengthen its over-the-counter (OTC) drug portfolio and expand the supply of essential medicines. In July, it launched the combination gastrointestinal drug "Peptomuse Suspension," and its glucose liquid product "Gluorange 100," used for gestational diabetes testing, was selected for the Ministry of Health and Welfare's "2026 Supply Instability Drug Production Support Project." Based on this, the company plans to improve its production facilities and expand annual production to about 1 million bottles by the year 2028.
The company expects that the expanded sales of new products launched in the second half of the year and stronger production collaborations with clients will contribute to the continued performance improvement of its subsidiaries.
Financial soundness has also improved. Following asset revaluation on owned land in the first half of this year, total consolidated equity at the end of the third quarter stood at 45.9 billion KRW, a 23.4% increase from 37.2 billion KRW at the end of last year.
"With the stable profit foundation of our coffee business combined with improved profitability from our pharmaceutical and health functional food subsidiaries, the effects of business diversification are beginning to show in our earnings," said Lee Eun-jung, CEO of Korea McNulty. "We will maintain this upward trend in performance by expanding sales channels for new products and strengthening production partnerships with clients."
[ⓒ Global Economic Times. 무단전재-재배포 금지]
WEEKLY HOT
- 1Executive at OpenAI Warns Artificial Intelligence Poses Rapid Existential Threat to Humanity
- 2Legacy Tech Failure Grounds Thousands: Inside the U.S. Air Traffic Collapse
- 3"Stay Out, Get Paid, or Have Police Stay With You": Shenzhen Imposes Strict Security Ahead of APEC Summit
- 4Digital Footprints as Crime: Japanese Court Sentences Woman for Repeated Social Media "Likes" on Ex-Partner’s Profile
- 5Behind the Persona: Biographer Exposes the 'Real' Jensen Huang
- 6US Aviation Authorities Under Fire After Friday Afternoon Equipment Upgrade Triggers Widespread Flight Groundings Despite Warnings